救济疗法与NeuroX合并,组成一家AI保健技术公司,侧重于脑健康。 Relief Therapeutics merges with NeuroX to form an AI health tech firm focusing on brain health.

救济治疗机构正与MindMaze的新业主NeuroX合并,以创建一家以AI为基础的公共保健技术公司。 Relief Therapeutics is merging with NeuroX, the new owner of MindMaze, to create a public AI-based health tech company. 这一新实体将整合软件治疗和药物,以改善大脑健康。 This new entity will integrate software treatments and drugs to improve brain health. NeuroX为这项交易带来了强大的投资组合和伙伴关系,预计这项交易将在2025年底结束,但须经批准。 NeuroX brings a strong portfolio and partnerships to the deal, which is expected to close by the end of 2025, subject to approvals.